Dutch pharmaceutical company uniQure says it plans to conduct preclinical studies leading to clinical testing of a gene therapy in patients…
Articles by Ana de Barros, PhD
Ionis Pharmaceuticals has completed enrollment of the Phase 1/2a study evaluating the safety, tolerability, properties and movement within the…
Taube Philanthropies has donated $3 million to fund a research team using gene editing and stem cell techniques to develop treatments…
Pope Francis will meet May 18 in the Vatican with patients and others who are fighting Huntington’s disease in what…
Teva Pharmaceutical Industries‘ Austedo tablets have received U.S. approval for treating chorea, or severe movement problems, associated with Huntington’s disease…
NUI Galway researcher and Professor Robert Lahue has been awarded a newly launched grant to investigate potential treatments for…
The European Union is inviting researchers in 20 countries to work together on projects focusing on Huntington’s disease (HD) and other…
A patent application for Vybion’s potential gene therapy for Huntington’s disease (HD) and other neurodegenerative conditions has been granted…
The University of North Carolina at Chapel Hill recently launched an initiative intended to better equip scientists working to treat rare and …
Critical Path Institute (C-Path) and CHDI Foundation have joined forces to create a consortium geared toward clearly defining regulatory pathways for…